Methyl 2-Furoate: An Alternative Reagent to Furan for Palladium-Catalysed Direct Arylation
作者:Hai Yan Fu、Henri Doucet
DOI:10.1002/ejoc.201101102
日期:2011.12
The palladium-catalyseddirectarylation of methyl 2-furoate with arylbromides was studied. The use of KOAc as the base, dimethylacetamide (DMAc) as the solvent and Pd(OAc)2 as the catalyst was found to give 5-arylfurans regioselectively and without decarboxylation. These methyl 5-aryl-2-furoates gave 2,5-diarylfurans by decarboxylative coupling by using Pd(OAc)2 as the catalyst. Methyl 2-furoate
Palladium-Catalyzed Decarboxylative Cross-Coupling Reaction Between Heteroaromatic Carboxylic Acids and Aryl Halides
作者:François Bilodeau、Marie-Christine Brochu、Nicolas Guimond、Kris H. Thesen、Pat Forgione
DOI:10.1021/jo9022793
日期:2010.3.5
A full overview of the decarboxylative cross-coupling reaction between heteroaromatic carboxylic acids and aryl halides is described. This transformation employs palladium catalysts with short reaction times providing facile synthesis of aryl-substituted heteroaromatics. The effect of each reaction parameter including solvent, base, and additive employed as well as the full substrate scope of this
Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them
申请人:Yi Yang Kyu
公开号:US20070299131A1
公开(公告)日:2007-12-27
The present invention relates to furancarbonylguanidine derivatives, a preparation method thereof and a pharmaceutical composition comprising the same. Furancarbonylguanidine derivatives of the present invention inhibit NHE-1 (sodium-hydrogen exchanger isoform 1), which helps recovery of heart function damaged from ischemia/reperfusion and decreases myocardial infarction rate, indicating that they have protective effect on myocardial cells. Thus, furancarbonylguanidine derivatives of the present invention can be effectively used for the prevention and the treatment of ischemic heart diseases such as myocardial infarction, arrhythmia, angina pectoris, etc, and also a promising candidate for a heart protecting agent applied to reperfusion therapy including thrombolytics or cardiac surgery including coronary artery bypass graft, percutaneous transluminal coronary angioplasty, etc.
(5-Arylfuran-2-ylcarbonyl)guanidines as Cardioprotectives through the Inhibition of Na<sup>+</sup>/H<sup>+</sup> Exchanger Isoform-1
作者:Sunkyung Lee、Kyu Yang Yi、Sun Kyung Hwang、Byung Ho Lee、Sung-eun Yoo、Kyunghee Lee
DOI:10.1021/jm0492305
日期:2005.4.1
A series of (5-arylfuran-2-ylcarbonyl)guanidines was synthesized and evaluated for the NHE-1 inhibitory activity and cardiprotective efficacy against ischemia-reperfusion injury. Starting with (5-phenylfuran-2-ylcarbonyl)guanidine 47 with a moderate inhibitory effect on NHE-1, the compounds with various substituents at the phenyl ring were investigated with the aim to optimize the potency. In this study, the 2,5-disubstituted compounds appeared to have better activities than the other analogues, and the 2-methoxy-5-chlorophenyl compound 85 was found as a potent inhibitor of NHE-1 (IC50 = 0.081 mu M). Furthermore, 85 showed a marked reduction of infarct size in the rat myocardial infarction model in vivo and significant improvement of cardiac contractile function in the isolated rat heart ischemia model in vitro.
Triflic Acid-Catalyzed Cycloisomerization Reactions of Donor–Acceptor Cyclopropanes: Access to Alkyl 5-Arylfuran-2-carboxylates
作者:Yuequan Zhu、Panpan Xu、Yuefa Gong
DOI:10.1021/acs.joc.6b00161
日期:2016.6.3
A direct synthetic strategy starting from alkyl 1-alkoxy-2-aroylcyclopropanecarboxylates was developed for the construction of alkyl 5-arylfuran-2-carboxylates. These donor acceptor cyclopropanes smoothly undergo a simple ring opening reaction or/and cycloisomerization reaction in the presence of acid at room temperature;, which greatly depends on the properties of the acid used in the experiment, Alkyl 5-arylfuran-2-carboxylates were afforded in high yields in triflic acid, whereas alkyl 2,5-dioxo-5-phenylpentanoate became the major product in other protic acids and Lewis acids.